Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Oral Oncol. 2016 Aug 31;61:62–69. doi: 10.1016/j.oraloncology.2016.08.012

Table 1.

Patient and Tumor Characteristics.

Characteristics of pts. Datum
Total no. of pts. (pts.) 215
Male 184 (85.6%)
Female 31 (14.4%)
Age (years) 57.21 ± 9.79 (range 27–91)
Height (cm.) 173.55 ± 8.96 (range 146–205.7)
Body weight (kg) 85.7 ± 18.1
Body mass index (kg/m2) 28.41 ± 5.46
Site of malignancy
Oral cavity 8 (3.7%)
Oropharynx 156 (72.6%)
Hyopopharynx 12 (5.6%)
Larynx 24 (11.1%)
Nasopharynx 6 (2.8%)
CUPa 6 (2.8%)
Sinus 3 (1.4%)
T category
T0 6 (2.8%)
T1 38 (17.7%)
T2 65 (30.2%)
T3 61 (28.3%)
T4 45 (20.9%)
N category
N0 25 (11.6%)
N1 23 (10.1%)
N2 150 (70.4%)
N3 17 (7.9%)
Stage
I 4 (1.9%)
II 5 (2.3%)
III 31 (14.4%)
IVA 156 (72.6%)
IVB 19 (8.8%)
Histology
Squamous cell 215 (100%)
Feeding Tube
Yes 118 (54.88%)
No 95 (44.19%)
NA 2 (0.93%)
Treatment Datum
Chemotherapy
Yes 130 (60.5%)
No 85 (39.5%)
Radiation Therapy
Mean Radiation dose (Gy) 68.66
No. of fraction (F) 33.35
a

CUP = cancer of unknown primary